Aggregation in Pharma

Product Traceability Beyond Boundaries

Aggregation in Pharma2019-09-05T12:18:54+09:30

Aggregation stands for a technology leap in the healthcare supply chain that can take a dimension similar to a blockchain in the financial industry.

Pharmaceutical companies will achieve considerable cost-savings by using traceability and aggregation solutions. A large part of these savings come from improvements in process and supply chain efficiency. Many companies see this solution as a major competitive advantage in today’s global economy.


Aggregation enables companies to trace their products from the moment of production, according to the parent-child principle. Once a blister pack is placed into a folding box (child), its serialisation code is scanned. In the next step, several folding boxes are packaged into a bundle (parent), and their serial numbers are linked to it. Several bundles can be also aggregated and related to a shipping box (the next higher-ranking parent level). This parent-child dataset is further linked to a pallet.

Aggregation of pharmaceutical products is a process, in which each participant in the supply chain takes over the information from the predecessor and additionally supplements it with its own data. This begins with the manufacturer, travels via the packaging to the third party logistics company (3PL), on to the wholesaler, etc. Each data aggregate is saved in a database before being passed on to the next participant in the supply chain.

Serialisation aggregation in the pharmaceutical industry